What is Wedbush’s Estimate for TCRX Q1 Earnings?
TScan Therapeutics, Inc. (NASDAQ:TCRX – Free Report) – Stock analysts at Wedbush issued their Q1 2026 earnings per share (EPS) estimates for TScan Therapeutics in a report released on Tuesday, May 6th. Wedbush analyst D. Nierengarten expects that the company will post earnings of ($0.23) per share for the quarter. Wedbush currently has a “Outperform” […]
